| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.913 | 0.003 | 0.913 | Anticonvulsant | |||
| 0.822 | 0.004 | 0.822 | Psychostimulant | 0.611 0.005 DBMET01529 | ||
| 0.814 | 0.001 | 0.814 | Benzodiazepine agonist | 0.08 0.039 DBMET01529 | ||
| 0.773 | 0.002 | 0.773 | GABA A receptor antagonist | |||
| 0.769 | 0.002 | 0.769 | GABA receptor antagonist | |||
| 0.768 | 0.003 | 0.768 | GABA receptor agonist | 0.095 0.084 DBMET01529 | ||
| 0.665 | 0.004 | 0.665 | GABA C receptor rho-3 antagonist | 0.212 0.193 DBMET01529 | ||
| 0.652 | 0.004 | 0.652 | Anesthetic general | 0.527 0.006 DBMET01529 | ||
| 0.388 | 0.024 | 0.388 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.303 | 0.005 | 0.303 | GABA C receptor rho-2 antagonist | |||
| 0.24 | 0.005 | 0.24 | Potassium channel activator | |||
| 0.227 | 0.004 | 0.227 | Cholecystokinin antagonist | |||
| 0.216 | 0.011 | 0.216 | Protein kinase C gamma inhibitor | 0.093 0.09 DBMET01529 | ||
| 0.2 | 0.013 | 0.2 | Interleukin 8 antagonist | |||
| 0.236 | 0.056 | 0.236 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.189 | 0.013 | 0.189 | Protein kinase C zeta inhibitor | |||
| 0.228 | 0.052 | 0.228 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.159 | 0.004 | 0.159 | Cholecystokinin B antagonist | |||
| 0.161 | 0.011 | 0.161 | Cyclin B3 inhibitor | |||
| 0.236 | 0.096 | 0.236 | Gastrin inhibitor | 0.197 0.154 DBMET01529 | ||
| 0.23 | 0.095 | 0.39 | Interleukin agonist | 0.39 0.02 DBMET01529 | DBMET01529 | |
| 0.151 | 0.021 | 0.151 | GABA C receptor rho-1 antagonist | |||
| 0.121 | 0.003 | 0.121 | Benzodiazepine antagonist | |||
| 0.207 | 0.089 | 0.211 | RNA-directed DNA polymerase inhibitor | 0.211 0.085 DBMET01529 | DBMET01529 | |
| 0.272 | 0.164 | 0.272 | Analgesic | |||
| 0.203 | 0.099 | 0.203 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.105 | 0.003 | 0.105 | Benzodiazepine receptor peripheral-type antagonist | 0.047 0.009 DBMET01529 | ||
| 0.136 | 0.039 | 0.136 | GABA C receptor antagonist | |||
| 0.109 | 0.015 | 0.109 | Protein kinase C eta inhibitor | 0.064 0.032 DBMET01529 | ||
| 0.123 | 0.034 | 0.123 | Electrolyte absorption antagonist | |||
| 0.121 | 0.034 | 0.121 | MAP kinase kinase 1 inhibitor | |||
| 0.151 | 0.064 | 0.259 | Cell wall synthesis inhibitor | 0.259 0.014 DBMET01529 | DBMET01529 | |
| 0.145 | 0.063 | 0.145 | Pregnane X receptor agonist | |||
| 0.13 | 0.051 | 0.13 | Cystathionine beta-synthase inhibitor | 0.108 0.069 DBMET01529 | ||
| 0.091 | 0.018 | 0.091 | Protein kinase C beta inhibitor | |||
| 0.182 | 0.112 | 0.182 | Aryl hydrocarbon receptor agonist | |||
| 0.088 | 0.022 | 0.088 | MAP kinase 7 inhibitor | |||
| 0.103 | 0.037 | 0.103 | Bromodomain-containing protein 2 inhibitor | |||
| 0.186 | 0.128 | 0.186 | DNA damaging | 0.166 0.15 DBMET01529 | ||
| 0.088 | 0.045 | 0.12 | Glycine receptor antagonist | 0.12 0.018 DBMET01529 | DBMET01529 | |
| 0.203 | 0.162 | 0.508 | Cholesterol antagonist | 0.508 0.031 DBMET01529 | DBMET01529 | |
| 0.067 | 0.032 | 0.067 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.067 | 0.034 | 0.067 | Plasminogen activator inhibitor | |||
| 0.036 | 0.006 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 DBMET01529 | ||
| 0.134 | 0.104 | 0.134 | Polo-like kinase-3 inhibitor | |||
| 0.091 | 0.066 | 0.091 | Protein kinase C mu inhibitor | |||
| 0.063 | 0.038 | 0.063 | Cyclin D1 inhibitor | |||
| 0.037 | 0.015 | 0.037 | Estrogen-related receptor beta antagonist | |||
| 0.19 | 0.173 | 0.19 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.05 | 0.033 | 0.05 | Bromodomain-containing protein 3 inhibitor | |||
| 0.062 | 0.049 | 0.062 | Kallikrein 7 inhibitor | |||
| 0.043 | 0.03 | 0.043 | GABA B receptor antagonist | |||
| 0.065 | 0.054 | 0.065 | MDM2 inhibitor | |||
| 0.122 | 0.111 | 0.122 | Sigma receptor agonist | |||
| 0.029 | 0.019 | 0.029 | Cyclin E2 inhibitor | |||
| 0.036 | 0.027 | 0.036 | Cholecystokinin A antagonist | |||
| 0.136 | 0.128 | 0.255 | ATPase inhibitor | 0.255 0.013 DBMET01529 | DBMET01529 | |
| 0.089 | 0.082 | 0.089 | Nav1.1 sodium channel blocker | |||
| 0.034 | 0.032 | 0.034 | Delayed rectifier potassium channel blocker | |||
| 0.032 | 0.029 | 0.032 | Protein kinase C beta I inhibitor | |||
| 0.039 | 0.038 | 0.134 | Phosphorylase inhibitor | 0.134 0.009 DBMET01529 | DBMET01529 | |
| 0.148 | 0.156 | 0.287 | Cyclic AMP phosphodiesterase inhibitor | 0.287 0.047 DBMET01529 | DBMET01529 | |
| 0.086 | 0.097 | 0.16 | Beta glucuronidase inhibitor | 0.16 0.021 DBMET01529 | DBMET01529 | |
| 0.08 | 0.092 | 0.096 | Glutamate release inhibitor | 0.096 0.049 DBMET01529 | DBMET01529 | |
| 0.021 | 0.046 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 DBMET01529 | DBMET01529 | |
| 0.105 | 0.132 | 0.13 | Mannose-6-phosphate isomerase inhibitor | 0.13 0.085 DBMET01529 | DBMET01529 | |
| 0.07 | 0.102 | 0.129 | NADH dehydrogenase inhibitor | 0.129 0.024 DBMET01529 | DBMET01529 | |
| 0.075 | 0.113 | 0.123 | DNA intercalator | 0.123 0.056 DBMET01529 | DBMET01529 | |
| 0.067 | 0.113 | 0.092 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.092 0.063 DBMET01529 | DBMET01529 | |
| 0.111 | 0.169 | 0.146 | Interleukin 6 antagonist | 0.146 0.095 DBMET01529 | DBMET01529 | |
| 0.014 | 0.073 | 0.071 | Trypsin I inhibitor | 0.071 0.008 DBMET01529 | DBMET01529 | |
| 0.059 | 0.121 | 0.198 | Topoisomerase I inhibitor | 0.198 0.027 DBMET01529 | DBMET01529 | |
| 0.092 | 0.167 | 0.169 | DNA repair enzyme inhibitor | 0.169 0.018 DBMET01529 | DBMET01529 | |
| 0.009 | 0.093 | 0.101 | Factor X inhibitor | 0.101 0.01 DBMET01529 | DBMET01529 | |
| 0.044 | 0.144 | 0.093 | Trypsin inhibitor | 0.093 0.02 DBMET01529 | DBMET01529 | |
| 0.039 | 0.14 | 0.112 | Topoisomerase II alpha inhibitor | 0.112 0.033 DBMET01529 | DBMET01529 | |
| 0.134 | 0.24 | 0.233 | DNA synthesis inhibitor | 0.233 0.08 DBMET01529 | DBMET01529 | |
| 0.133 | 0.249 | 0.355 | Peptidyltransferase inhibitor | 0.355 0.011 DBMET01529 | DBMET01529 | |
| 0.079 | 0.2 | 0.123 | Diuretic | 0.123 0.102 DBMET01529 | DBMET01529 | |
| 0.051 | 0.177 | 0.123 | UDP-glucose 4-epimerase inhibitor | 0.123 0.042 DBMET01529 | DBMET01529 | |
| 0.197 | 0.324 | 0.272 | Caspase 9 stimulant | 0.272 0.226 DBMET01529 | DBMET01529 | |
| 0.007 | 0.172 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.016 DBMET01529 | DBMET01529 | |
| 0.08 | 0.247 | 0.185 | Hemostatic | 0.185 0.039 DBMET01529 | DBMET01529 | |
| 0.018 | 0.195 | 0.079 | Protein 50S ribosomal subunit inhibitor | 0.079 0.02 DBMET01529 | DBMET01529 | |
| 0.033 | 0.211 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.034 DBMET01529 | DBMET01529 | |
| 0.024 | 0.212 | 0.075 | Heparanase inhibitor | 0.075 0.009 DBMET01529 | DBMET01529 | |
| 0.008 | 0.204 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.017 DBMET01529 | DBMET01529 | |
| 0.079 | 0.277 | 0.184 | Non-steroidal antiinflammatory agent | 0.184 0.084 DBMET01529 | DBMET01529 | |
| 0.045 | 0.253 | 0.181 | Lipid peroxidase inhibitor | 0.181 0.05 DBMET01529 | DBMET01529 | |
| 0.043 | 0.267 | 0.104 | DNA polymerase I inhibitor | 0.104 0.082 DBMET01529 | DBMET01529 | |
| 0.122 | 0.349 | 0.319 | Apoptosis antagonist | 0.319 0.073 DBMET01529 | DBMET01529 | |
| 0.095 | 0.336 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.048 DBMET01529 | DBMET01529 | |
| 0.059 | 0.317 | 0.141 | Hexokinase inhibitor | 0.141 0.09 DBMET01529 | DBMET01529 | |
| 0.01 | 0.272 | 0.092 | Antineoplastic antibiotic | 0.092 0.05 DBMET01529 | DBMET01529 | |
| 0.12 | 0.395 | 0.359 | Interleukin 2 agonist | 0.359 0.042 DBMET01529 | DBMET01529 | |
| 0.108 | 0.386 | 0.276 | Histamine release inhibitor | 0.276 0.137 DBMET01529 | DBMET01529 | |
| 0.09 | 0.37 | 0.442 | Antithrombotic | 0.442 0.04 DBMET01529 | DBMET01529 | |
| 0.033 | 0.317 | 0.056 | Lipocortins synthesis agonist | 0.056 0.046 DBMET01529 | DBMET01529 | |
| 0.007 | 0.296 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.015 DBMET01529 | DBMET01529 | |
| 0.027 | 0.326 | 0.136 | Topoisomerase II inhibitor | 0.136 0.056 DBMET01529 | DBMET01529 | |
| 0.063 | 0.367 | 0.357 | Antioxidant | 0.357 0.044 DBMET01529 | DBMET01529 | |
| 0.1 | 0.429 | 0.206 | Caspase 3 stimulant | 0.206 0.16 DBMET01529 | DBMET01529 | |
| 0.041 | 0.371 | 0.13 | Cyclooxygenase 3 inhibitor | 0.13 0.067 DBMET01529 | DBMET01529 | |
| 0.048 | 0.388 | 0.316 | Free radical scavenger | 0.316 0.047 DBMET01529 | DBMET01529 | |
| 0.051 | 0.434 | 0.164 | NOS3 expression enhancer | 0.164 0.06 DBMET01529 | DBMET01529 | |
| 0.076 | 0.461 | 0.446 | Antibacterial | 0.446 0.058 DBMET01529 | DBMET01529 | |
| 0.033 | 0.439 | 0.28 | Immunostimulant | 0.28 0.085 DBMET01529 | DBMET01529 | |
| 0.02 | 0.428 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.086 0.064 DBMET01529 | DBMET01529 | |
| 0.028 | 0.448 | 0.121 | Anticoagulant | 0.121 0.11 DBMET01529 | DBMET01529 | |
| 0.021 | 0.446 | 0.23 | Acetylcholinesterase inhibitor | 0.23 0.025 DBMET01529 | DBMET01529 | |
| 0.067 | 0.493 | 0.271 | Immunomodulator | 0.271 0.099 DBMET01529 | DBMET01529 | |
| 0.015 | 0.455 | 0.054 | Glucose-6-phosphate translocase inhibitor | 0.054 0.031 DBMET01529 | DBMET01529 | |
| 0.021 | 0.462 | 0.089 | AMP-activated protein kinase stimulant | 0.089 0.087 DBMET01529 | DBMET01529 | |
| 0.028 | 0.492 | 0.121 | Toll-Like receptor 4 antagonist | 0.121 0.043 DBMET01529 | DBMET01529 | |
| 0.066 | 0.579 | 0.341 | Apoptosis agonist | 0.341 0.144 DBMET01529 | DBMET01529 | |
| 0.038 | 0.581 | 0.324 | Immunosuppressant | 0.324 0.101 DBMET01529 | DBMET01529 | |
| 0.015 | 0.571 | 0.049 | Factor IXa inhibitor | 0.049 0.038 DBMET01529 | DBMET01529 | |
| 0.019 | 0.579 | 0.202 | Cholinergic | 0.202 0.046 DBMET01529 | DBMET01529 | |
| 0.011 | 0.582 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 DBMET01529 | DBMET01529 | |
| 0.022 | 0.621 | 0.203 | Transcription factor NF kappa B inhibitor | 0.203 0.166 DBMET01529 | DBMET01529 | |
| 0.033 | 0.638 | 0.282 | Hepatoprotectant | 0.282 0.035 DBMET01529 | DBMET01529 | |
| 0.017 | 0.665 | 0.195 | Nitric oxide antagonist | 0.195 0.069 DBMET01529 | DBMET01529 | |
| 0.014 | 0.697 | 0.11 | Cell adhesion inhibitor | 0.11 0.074 DBMET01529 | DBMET01529 | |
| 0.033 | 0.751 | 0.43 | Antiinflammatory | 0.43 0.121 DBMET01529 | DBMET01529 | |
| 0.023 | 0.769 | 0.334 | Hypoglycemic | 0.334 0.042 DBMET01529 | DBMET01529 | |
| 0.004 | 0.75 | 0.219 | Selectin antagonist | 0.219 0.01 DBMET01529 | DBMET01529 | |
| 0.011 | 0.78 | 0.414 | Angiogenesis stimulant | 0.414 0.02 DBMET01529 | DBMET01529 | |
| 0.02 | 0.841 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.059 DBMET01529 | DBMET01529 | |
| 0.009 | 0.893 | 0.162 | Platelet adhesion inhibitor | 0.162 0.094 DBMET01529 | DBMET01529 | |
| 0.006 | 0.9 | 0.142 | Thrombolytic | 0.142 0.088 DBMET01529 | DBMET01529 | |
| 0.005 | 0.94 | 0.342 | Cyclophilin D inhibitor | 0.342 0.129 DBMET01529 | DBMET01529 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |